I thought maybe this product might be rival technology to Sirna Dermatology's investigation into an RNA interfering product called Trichozyme. Trichozyme would be applied directly to the skin and the medicine would reach the bottom of the hair and interfer with the protein production which is necessary for causing hair growth.
Here's what they wrote:
"Quest PharmaTech Inc. Receives Health Canada Clearance
Quest PharmaTech Inc. (Edmonton) announced that its contract research partner, Innovaderm Inc. has received clearance from the Therapeutic Products Directorate of Health Canada to initiate a Phase I clinical trial to investigate the topical application of its lead photodynamic therapy (PDT) compound SL017 as a treatment for acne and also for the removal of unwanted hair. The Principal Investigator for the trial is Dr. Robert Bissonnette MD. This planned study will be in addition to the Phase I clinical trial of ACP-SL017 for photodynamic therapy of Actinic Keratosis ("AK"), which is currently underway at the University of Alberta, with Dr. Jaggi Rao as the Principal Investigator. The results from this trial are expected to be available in Q1 of this year."
This is light therapy plus topical medication?? You could e-mail the company for clarification. I'm aware of Sirna's efforts, but not familiar with this. Sorry. If there are some hairy researchers types that read hairtell, please help out if you can.
Dee Fahey, R.N., C.T.
Licensed by the State Medical Board of Ohio for Nursing license and Cosmetic Therapy/Electrolysis license
British Institute & Association of Electrolysishttp://www.electrolysis.co.uk/?page_id=16
Do not give up, the beginning is always the hardest.